COVID-19 | New Zealand approves use of Janssen vaccine

New Zealand Covid-19 Response Minister Chris in Wellington. File photo   | Photo Credit: AP

New Zealand said on Wednesday, July 7, 2021, that its health regulator Medsafe has given provisional approval for a coronavirus vaccine developed by Janssen, the pharmaceutical unit of Johnson & Johnson.

The Janssen COVID-19 vaccine was approved for individuals 18 years of age and older, COVID-19 Response Minister Chris Hipkins said in an announcement.

"The medical evidence shows Janssen is a very safe and effective vaccine. It is a great addition to our vaccineoptions," Mr. Hipkins said, adding that the country had secured 2 million doses of the Janssen vaccine through an advance purchase agreement last year.

Our code of editorial values

Related Topics
This article is closed for comments.
Please Email the Editor

Printable version | Oct 19, 2021 11:22:37 PM |

Next Story